Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP833117.RAgZgBO_3AVCnhQHriHodrPLGsyRRhx8nMHM5bjWnLE0s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP833117.RAgZgBO_3AVCnhQHriHodrPLGsyRRhx8nMHM5bjWnLE0s130_assertion type Assertion NP833117.RAgZgBO_3AVCnhQHriHodrPLGsyRRhx8nMHM5bjWnLE0s130_head.
- NP833117.RAgZgBO_3AVCnhQHriHodrPLGsyRRhx8nMHM5bjWnLE0s130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP833117.RAgZgBO_3AVCnhQHriHodrPLGsyRRhx8nMHM5bjWnLE0s130_provenance.
- NP833117.RAgZgBO_3AVCnhQHriHodrPLGsyRRhx8nMHM5bjWnLE0s130_assertion evidence source_evidence_literature NP833117.RAgZgBO_3AVCnhQHriHodrPLGsyRRhx8nMHM5bjWnLE0s130_provenance.
- NP833117.RAgZgBO_3AVCnhQHriHodrPLGsyRRhx8nMHM5bjWnLE0s130_assertion SIO_000772 18387633 NP833117.RAgZgBO_3AVCnhQHriHodrPLGsyRRhx8nMHM5bjWnLE0s130_provenance.
- NP833117.RAgZgBO_3AVCnhQHriHodrPLGsyRRhx8nMHM5bjWnLE0s130_assertion wasDerivedFrom befree-20150227 NP833117.RAgZgBO_3AVCnhQHriHodrPLGsyRRhx8nMHM5bjWnLE0s130_provenance.
- NP833117.RAgZgBO_3AVCnhQHriHodrPLGsyRRhx8nMHM5bjWnLE0s130_assertion wasGeneratedBy ECO_0000203 NP833117.RAgZgBO_3AVCnhQHriHodrPLGsyRRhx8nMHM5bjWnLE0s130_provenance.